Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients
about
In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasisHigh aspartyl proteinase production and vaginitis in human immunodeficiency virus-infected womenElevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episodeCell wall and secreted proteins of Candida albicans: identification, function, and expressionImpact of N-chlorotaurine on viability and production of secreted aspartyl proteinases of Candida spp.Interaction of serotonin with Candida albicans selectively attenuates fungal virulence in vitro.Candida albicans secreted aspartyl proteinases in virulence and pathogenesisImmunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.Drosophila p24 and Sec22 regulate Wingless trafficking in the early secretory pathway.Differential expression of secretory aspartyl proteinase genes (SAP1-10) in oral Candida albicans isolates with distinct karyotypes.Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients.Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection.Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase.Basidiomycete metabolites attenuate virulence properties of Candida albicans in vitro.Estimation of biofilm, proteinase & phospholipase production of the Candida species isolated from the oropharyngeal samples in HIV-infected patients.Protection against systemic candidiasis in mice immunized with secreted aspartic proteinase 2.
P2860
Q33867435-CA6C26F3-EE90-4472-AD12-A6DA0D48294BQ33960136-385DD8CE-C637-4895-9682-9EE02DAA0E01Q33969896-99AC4EEC-A349-4747-BCEE-865B81034B48Q34009982-EE44841C-992C-492E-B7DE-063533E4D4B6Q34108727-0B96B0A6-678F-43E6-9813-6C6578A2F46EQ34307586-EBCF973B-B5FC-44FD-9E29-A63675BA5044Q35215948-5192A853-CDFC-40DF-85FF-4EE9FFDC377CQ35920633-DA156ED4-FC43-4068-81C7-1EEB4F2CBF26Q36610369-D846EB96-0293-4491-8997-EEE76C5CA8BFQ37576120-FF80401C-8780-41B7-8869-FD56ED7FD2FFQ39471544-13778BB7-A57A-41D3-9854-285D0911A285Q39789893-C60ACF85-4A81-48DA-9B8B-64908DAA4151Q39826475-5C94363E-4348-4DAF-B423-2ACD34278C8AQ39990721-B70AF3DF-11F4-4134-8EDD-E9F54B4BC0E2Q42689563-7C4804D4-43C3-430F-9354-6A325DF7AE0EQ44792128-4B668D4F-F94C-4595-B988-8F30C0AE8B08
P2860
Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Increased expression of Candid ...... ciency virus-positive patients
@ast
Increased expression of Candid ...... ciency virus-positive patients
@en
type
label
Increased expression of Candid ...... ciency virus-positive patients
@ast
Increased expression of Candid ...... ciency virus-positive patients
@en
prefLabel
Increased expression of Candid ...... ciency virus-positive patients
@ast
Increased expression of Candid ...... ciency virus-positive patients
@en
P2093
P2860
P1476
Increased expression of Candid ...... ciency virus-positive patients
@en
P2093
Borg-von Zepelin M
Korting HC
McMullan-Vogel CG
P2860
P304
P407
P577
1995-10-01T00:00:00Z